With marketed products we know what it takes to make your product a success

Nordmark can refer to a significant track record in the industry with successful different process development and manufacturing projects in various stages of clinical development as well as approved and marketed products for more than 40 international partners.

Selected biotech projects:

PartnerProductActivities
BIOCEUTICALSEPO Biosimilar (CHO)

Process development

GMP-production of clinical material PH III

Planning, building and operationally running the GMP-production site    
advanceCor     Recombinant fusion protein (CHO)        

Process development

GMP-production of preclinical and clinical material PH I        
Ticeba     Monoclonal antibody        Purification process development, GMP production      
CT Atlantic    

Monoclonal

antibody       
Process development  and GMP production
Nordmark proprietary         Ancrod, non-recombinant protein        Process development PHI/II and GMP production, formulation and primary packaging development     
Nordmark proprietary         Burlulipase, non-recombinant protein         Process development PHI/II and GMP production, formulation and primary packaging development           
Nordmark proprietary        Collagenase, non-recombinant protein        Process development and GMP production, formulation and primary packaging development        

Download

Contact

Nordmark Biotech
Dr. Jan Heyland
Pinnauallee 4
25436 Uetersen
T +49 (0) 4122 712 907
F +49 (0) 4122 712 545
projects(at)nordmark-biotech.de